Amberstone Biosciences Inc
23181 Verdugo Dr. Ste 106
4 articles about Amberstone Biosciences Inc
Amberstone Biosciences Announces Formation of Scientific Advisory Board
Amberstone Biosciences is announcing the formation of a scientific advisory board comprised of industry leaders in drug delivery, oncology, immunology and pharmaceutical sciences.
Here's who rang in the New Year by joining the NASDAQ or raising private equity funds.
Amberstone Biosciences Secures $12 Million Series A Financing to Advance Immuno-Oncology Pipeline of Tumor Microenvironment Activated Therapeutics
Amberstone Biosciences, an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, announced the completion of a $12 million Series A financing round.
With $12 million in hand from a Series A investment round, Amberstone Biosciences aims at cancer with its highly-differentiated tumor microenvironment-activated therapeutic programs.